Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Polo

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Photoacoustics|March 18, 2024
Study of erythrocyte sedimentation in human blood through the photoacoustic signals analysisArgelia Pérez-Pacheco, Roberto G Ramírez-Chavarría, Marco Polo Colín-García, et al.
Vaccine|November 10, 2024
Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal routeMarco Polo Peralta Alvarez, Keya Downward, Andrew White, et al.
Vaccine|May 4, 2019
Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact componentsSofiya Fedosyuk, Thomas Merritt, Marco Polo Peralta-Alvarez, et al.
Therapeutic Advances in Respiratory Disease|July 10, 2020
Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countriesAndrés F Cardona, Oscar Arrieta, Alejandro Ruiz-Patiño, et al.
Frontiers in Immunology|May 27, 2024
Low-dose <i>M.tb</i> infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primatesMarco Polo Peralta Alvarez, Holly Jones, Hugo Redondo Azema, et al.
NPJ Vaccines|November 20, 2024
MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primatesMarco Polo Peralta-Álvarez, Keya Downward, Andrew White, et al.
JAMA Oncology|April 10, 2020
Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical TrialOscar Arrieta, Feliciano Barrón, Laura Alejandra Ramírez-Tirado, et al.
Vaccines|June 25, 2026
Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency ResponseMarco Polo Peralta Alvarez, Shawkat Hussain, Andrea Magri, et al.
Frontiers in Immunology|January 24, 2022
Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG VaccinationJulia Bitencourt, Marco Polo Peralta-Álvarez, Morven Wilkie, et al.
Nature Communications|May 29, 2025
Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCGJulia L Marshall, Iman Satti, Mirvat Surakhy, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Photoacoustics|March 18, 2024
Study of erythrocyte sedimentation in human blood through the photoacoustic signals analysisArgelia Pérez-Pacheco, Roberto G Ramírez-Chavarría, Marco Polo Colín-García, et al.
Vaccine|November 10, 2024
Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal routeMarco Polo Peralta Alvarez, Keya Downward, Andrew White, et al.
Vaccine|May 4, 2019
Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact componentsSofiya Fedosyuk, Thomas Merritt, Marco Polo Peralta-Alvarez, et al.
Therapeutic Advances in Respiratory Disease|July 10, 2020
Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countriesAndrés F Cardona, Oscar Arrieta, Alejandro Ruiz-Patiño, et al.
Frontiers in Immunology|May 27, 2024
Low-dose <i>M.tb</i> infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primatesMarco Polo Peralta Alvarez, Holly Jones, Hugo Redondo Azema, et al.
NPJ Vaccines|November 20, 2024
MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primatesMarco Polo Peralta-Álvarez, Keya Downward, Andrew White, et al.
JAMA Oncology|April 10, 2020
Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical TrialOscar Arrieta, Feliciano Barrón, Laura Alejandra Ramírez-Tirado, et al.
Vaccines|June 25, 2026
Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency ResponseMarco Polo Peralta Alvarez, Shawkat Hussain, Andrea Magri, et al.
Frontiers in Immunology|January 24, 2022
Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG VaccinationJulia Bitencourt, Marco Polo Peralta-Álvarez, Morven Wilkie, et al.
Nature Communications|May 29, 2025
Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCGJulia L Marshall, Iman Satti, Mirvat Surakhy, et al.
Pageof 5